@article{e7b553e246c047b38197e6ea3af2f2ff,
title = "Clinical Consensus Statement: Balloon Dilation of the Eustachian Tube",
abstract = "Objective: To develop a clinical consensus statement on the use of balloon dilation of the eustachian tube (BDET). Methods: An expert panel of otolaryngologists was assembled with nominated representatives of general otolaryngology and relevant subspecialty societies. The target population was adults 18 years or older who are candidates for BDET because of obstructive eustachian tube dysfunction (OETD) in 1 or both ears for 3 months or longer that significantly affects quality of life or functional health status. A modified Delphi method was used to distill expert opinion into clinical statements that met a standardized definition of consensus. Results: After 3 iterative Delphi method surveys, 28 statements met the predefined criteria for consensus, while 28 statements did not. The clinical statements were grouped into 3 categories for the purposes of presentation and discussion: (1) patient criteria, (2) perioperative considerations, and (3) outcomes. Conclusion: This panel reached consensus on several statements that clarify diagnosis and perioperative management of OETD. Lack of consensus on other statements likely reflects knowledge gaps regarding the role of BDET in managing OETD. Expert panel consensus may provide helpful information for the otolaryngologist considering the use of BDET for the management of patients with OETD.",
keywords = "balloon dilation, consensus, eustachian tube dysfunction, nasal endoscopy, otitis media, otoscopy, tympanometry",
author = "Tucci, {Debara L.} and McCoul, {Edward D.} and Rosenfeld, {Richard M.} and Tunkel, {David E.} and Batra, {Pete S.} and Chandrasekhar, {Sujana S.} and Cordes, {Susan R.} and Eshraghi, {Adrien A.} and David Kaylie and Devyani Lal and Jivianne Lee and Michael Setzen and Raj Sindwani and Syms, {Charles A.} and Charles Bishop and Poe, {Dennis S.} and Maureen Corrigan and Erin Lambie",
note = "Funding Information: Competing interests: Debara L. Tucci, consultant for Otonomy, Otic Pharma, and Frequency. Edward D. McCoul, consultant for Acclarent. David E. Tunkel, consultant for Otic Pharma; spouse is lecturer and investigator for Allergan, Galderma. Pete S. Batra, consultant for Optinose, Regeneron, and Acclarent; textbook royalties from Springer; research grant from Medtronic; advisory board for Optinose, Regeneron. Sujana S. Chandrasekhar, consulting fee from US FDA, OTIC Pharma, Tuska Pharma, and Castle Creek Pharma; consulting editor for Otolaryngologic Clinics of North America; secretary-treasurer of the AOS; honoraria from Kurz Corporation; research funding from AAO-HNS WIOS and Sound Pharma; stock in Scientific Development & Research; expert witness for defendant for VPBB Las (GYN MD) and University of Miami (ENT MD); shareholder for Novus Therapeutics, Alrich; board member, Scientific Development & Research, Alrich; advisory board, Tusker Medical. Susan R. Cordes, honorarium from Otonomy; dinner from Intersect, Entellus, and Acclarent. Adrien A. Eshraghi, research grants through Medel, Auris Medical, and Otonomy; travel reimbursement from Medel and Auris Medical; consultant for Auris Medical. David Kaylie, Acclarent speaker. Jivianne Lee, clinical trial for Intersect. Michael Setzen, consultant for Arrinex. Raj Sindwani, consultant for Medtronic, Olympus, and Acclarent (not related to balloons). Charles A. Syms, Earlens Corporation, advisory board and equity; Tuskeo Medical, advisory board equity; Arrinex Corporation, advisory board equity; Cochlear Corporation, audiology support for the practice; Audigy, medical consultant; UTHSC–San Antonio, clinical professor and resident teaching; Earlens and Tusker Medical, research funding. Maureen Corrigan, salaried employee of AAO-HNSF. Erin Lambie, salaried employee of AAO-HNSF. Dennis S. Poe, consultant for Acclarent and principal investigator for clinical trial; Otodyne Corp—spouse owns stock in this startup company making nasal spray for otitis media. Sponsorships: American Academy of Otolaryngology–Head and Neck Surgery Foundation. Funding source: None. Funding Information: We gratefully acknowledge the support of Sarah Towner Wright, MLS, for conducting the literature searches. We also thank Charles Bishop, AuD, PhD, CCC-A and Dennis Poe, MD for the consulting contributions and Lisa Satterfield, MS, MPH, CCC-A, CAE, for her guidance in the development process. The follow organizations have endorsed this clinical consensus statement: the American Academy of Otolaryngic Allergy, American Neurotology Society, American Otological Society, American Rhinologic Society, American Speech-Language-Hearing Association, and Triological Society. Publisher Copyright: {\textcopyright} American Academy of Otolaryngology–Head and Neck Surgery Foundation 2019.",
year = "2019",
month = jul,
day = "1",
doi = "10.1177/0194599819848423",
language = "English (US)",
volume = "161",
pages = "6--17",
journal = "Otolaryngology - Head and Neck Surgery (United States)",
issn = "0194-5998",
publisher = "Mosby Inc.",
number = "1",
}